Literature DB >> 27941771

Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation.

S Fuji1,2, J Löffler2, B N Savani3, H Einsele2, M Kapp2.   

Abstract

Diabetes mellitus (DM) is well-known as a disorder that increases the risk of infectious diseases. Various reports have shown that innate immunity is impaired in patients with DM, which is considered to be a major cause of increased risk of infectious diseases. However, there is a paucity of data about the actual risk of mold infections in patients with DM. Several treatment procedures, such as solid organ transplantation and hematopoietic stem cell transplantation (HSCT), are intrinsically associated with a high risk of mold infections and also correlated with an increased risk of post-transplant DM. Therefore, we could assume that organ transplant recipients or HSCT recipients with DM are at quite high risk of mold infections. Here, we aim to summarize the information about the increased risk of mold infections in patients with DM, and propose possible interventions such as intensive glucose control to reduce this risk in patients with DM.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27941771     DOI: 10.1038/bmt.2016.306

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

1.  Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study.

Authors:  Yoshitaka Inoue; Keiji Okinaka; Shigeo Fuji; Yoshihiro Inamoto; Naoyuki Uchida; Takashi Toya; Kazuhiro Ikegame; Tetsuya Eto; Yukiyasu Ozawa; Koji Iwato; Yoshinobu Kanda; Yoshiko Atsuta; Masao Ogata; Takahiro Fukuda
Journal:  Bone Marrow Transplant       Date:  2021-04-19       Impact factor: 5.483

2.  Trajectories of Fasting Blood Glucose in Autologous Hematopoietic Cell Transplantation.

Authors:  Marilyn J Hammer; Steven M Paul; Amir Steinberg; Patricia Eckardt; Margaret Barton-Burke; Christine Miaskowski
Journal:  Cancer Nurs       Date:  2019 Jul/Aug       Impact factor: 2.592

3.  Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients.

Authors:  Jenna Sopfe; Laura Pyle; Amy K Keating; Kristen Campbell; Arthur K Liu; R Paul Wadwa; Michael R Verneris; Roger H Giller; Gregory P Forlenza
Journal:  Blood Adv       Date:  2019-02-12

4.  How I transplant a patient with a history of invasive fungal disease.

Authors:  Pedro Puerta-Alcalde; Richard Champlin; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2020-08-26       Impact factor: 22.113

5.  How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease.

Authors:  Pedro Puerta-Alcalde; Richard E Champlin; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2020-12-10       Impact factor: 22.113

Review 6.  COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic.

Authors:  Pankaj Chandley; Priyanka Subba; Soma Rohatgi
Journal:  Vaccines (Basel)       Date:  2022-08-06

Review 7.  Aspergillus Genus and Its Various Human Superficial and Cutaneous Features.

Authors:  Yassine Merad; Hichem Derrar; Zoubir Belmokhtar; Malika Belkacemi
Journal:  Pathogens       Date:  2021-05-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.